Holdings
NEXTBio Capital Management LP
As of Jun 30, 2026, NEXTBio Capital Management LP reported 19 positions worth US$172M. Largest: Protagonist Therapeutics, Inc., Shattuck Labs, Inc. and Vor Biopharma Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Protagonist Therapeutics, Inc. | 219K | US$26.9M | −10,286 | Jun 30, 2026 |
| Shattuck Labs, Inc. | 3.73M | US$25.9M | +577K | Jun 30, 2026 |
| Vor Biopharma Inc. | 889K | US$16.4M | −111K | Jun 30, 2026 |
| Rhythm Pharmaceuticals, Inc. | 132K | US$14.6M | +5,680 | Jun 30, 2026 |
| Palvella Therapeutics, Inc. | 89,909 | US$13.7M | +7,223 | Jun 30, 2026 |
| Xenon Pharmaceuticals Inc. | 183K | US$11.1M | no change | Jun 30, 2026 |
| Zenas Biopharma, Inc. | 427K | US$10.8M | no change | Jun 30, 2026 |
| Oric Pharmaceuticals, Inc. | 706K | US$7.65M | +183K | Jun 30, 2026 |
| Inventiva Sa | 1.79M | US$6.76M | +455K | Jun 30, 2026 |
| Crescent Biopharma, Inc. | 373K | US$6.71M | no change | Jun 30, 2026 |